Potential use of Gabapentin and Lamotrigine

Abstract

Get full access to this article

View all access options for this article.

References

Swash

, Schwartz

. What do we really know about amyotrophic lateral sclerosis? J Neurol Sci 1992; 113: 4–16.

Schwartz

, Swash

Motor neuron disease. In: Swash

, Oxbury

eds. Clinical neurology. 1st ed. New York: Churchill Livingstone, 1991: 1356–66.

Eisen

, Stewart

, Schulzer

, Cameron

Anti-glutamate therapy in amyotrophic lateral sclerosis: a trial using lamotrigine. Can J Neurol Sci 1993; 20: 297–301.

Bensiman

, Lacomblez

, Meininger

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 1994; 330: 585–91.

Plaitakis

Altered glutaminergic mechanisms and selective motor neuron degeneration in amyotrophic lateral sclerosis: possible role of glycine. Adv Neurol 1991; 56: 319–26.

Price

, Koliatsob

, Clatterbuck

. Cholinergic systems: human diseases, animal models, and prospects for therapy. Prog Brain Res 1993; 98: 51–60.

Rothstein

, Martin

, Kunci

. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 1992; 326: 1464–8.

Taylor

. Emerging perspectives on the mechanism of action of gabapentin. Neurology 1994; 44(suppl 5):S10–6.

McLean

. Clinical pharmacokinetics of gabapentin. Neurology 1994; 44(suppl 5):S17–22.

10.

Goa

, Ross

, Chrisp

Lamotrigine: a review of its pharmacological properties and clinical efficacy in epilepsy. Drugs 1993; 46: 152–76.